Shanghai Fosun Pharmaceutical (Group) Co. Ltd. has announced new management changes following their annual general meeting on June 24, 2025. Mr. Chen Yuqing has been appointed as Chairman of the Board, with Ms. Guan Xiaohui as Co-Chairman and Mr. Wen Deyong as Vice Chairman. Mr. Liu Yi will take on the role of Chief Executive Officer and President. Additionally, Ms. Li Jing, Mr. Xingli Wang, and Mr. Wenjie Zhang will serve as Co-Presidents. The company aims to accelerate its innovation transformation and global development under the new leadership.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.